Test - Ascendis Pharma JP

NEWS RELEASES

February 16, 2023

Ascendis Pharma Reports Full Year 2022 Results

February 7, 2023

Ascendis Pharma Announces Full Year 2022 Financial Results and Business Update Conference Call on February 16

January 8, 2023

Ascendis Pharma Provides Update on Vision 3x3 Strategic Roadmap at 41st Annual J.P. Morgan Healthcare Conference

Preclinical

Phase 1

Phase 2

Phase 3

TransCon hGH

Pediatric growth hormone deficiency2

test

Phase 1

test

Adult growth hormone deficiency

Phase 1

TransCon PTH

Adult hypoparathyroidism

Phase 2

Preclinical

Phase 1

Phase 2

Phase 3

sss

Phase 1

sdsd

sss

Phase 2

sss

sds

Phase 3

You are about to access www.ascendispharma.us, which includes information intended for U.S. residents only. Click below to confirm.

CONFIRM DENY

You are about to access www.ascendispharma.com. Click below if you wish to proceed.

CONFIRM DENY

You are about to leave the Ascendis Pharma website and will continue on an external website. Ascendis Pharma takes no responsibility for the content of such external website

CONFIRM DENY